Morgan Stanley analyst Thibault Boutherin upgraded Bayer (BAYRY) to Overweight from Equal Weight with a price target of EUR 40, up from EUR 29. The firm views the company as a “tactical valuation play” into 2026 due to its positive litigation developments and improving fundamentals.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY: